Want to join the conversation?
Dara Mohsenian of Morgan Stanley asks about visibility of 4% organic sales growth and the North American carbonated soft drink pricing environment. $PEP CEO Indra Nooyi said that about visibility, the company can talk about what it controls; innovation pipeline is looking good. On pricing, the company is seeing a lot of discipline in pricing.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.